Table 1. Patient demographic characteristics.
No. | Age | Gender | Handedness | Duration of illness (years) | Medication (daily doses) |
NF group | |||||
1 | 54 | M | L | 1 | lofepramine 140 mg, mirtazapine 30 mg |
2 | 67 | M | R | 49 | amitriptyline 75 mg |
3 | 37 | M | R | 6 | tranylcypromin 40 mg, lithium 400 mg |
4 | 21 | M | R | 2 | fluoxetine 40 mg |
5 | 44 | M | R | 20 | mirtazapine 30 mg |
6 | 56 | M | R | 20 | sertraline 200 mg, reboxetine 8 mg |
7 | 47 | M | R | 25 | citalopram 60 mg, quetiapine 100 mg |
8 | 61 | M | R | 31 | fluoxetine 20 mg |
IM group | |||||
9 | 39 | M | R | 20 | duloxetine 60 mg |
10 | 59 | M | R | 9 | lithium 1200 mg, venlafaxine 225 mg |
11 | 65 | F | R | 40 | sertraline 100 mg |
12 | 49 | M | R | 20 | reboxetine 4 mg |
13 | 64 | F | R | 12 | citalopram 20 mg |
14 | 29 | M | L | 18 | citalopram 30 mg |
15 | 44 | F | R | 20 | citalopram 20 mg |
16 | 39 | M | R | 14 | citalopram 40 mg |